|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.34 EUR | +0.25% |
|
-0.03% | -6.91% |
| 07-28 | European Equities Traded in US as ADRs Ease in Tuesday Trading | MT |
| 07-27 | Oddo BHF stays positive on Sanofi after a program is halted |  |
| Market Cap | 96.07B 109B 89.68B 82.3B 154B 10,473B 158B 1,063B 416B 5,182B 411B 402B 17,915B | P/E 2026 * |
12x | P/E 2027 * | 11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 106B 120B 98.83B 90.7B 170B 11,541B 174B 1,172B 458B 5,711B 452B 443B 19,743B | EV / Sales 2026 * |
2.25x | EV / Sales 2027 * | 2.03x |
| Free-Float |
89.21% | Yield 2026 * |
5.33% | Yield 2027 * | 5.64% |
Last Transcript: Sanofi
| 1 week | +2.63% | ||
| Current month | +5.97% | ||
| 1 month | +5.11% | ||
| 3 months | +0.16% | ||
| 6 months | +2.51% | ||
| Current year | -4.70% |
| 1 week | 74.1 |  | 80.13 |
| 1 month | 72.8 | | 80.13 |
| 3 years | 71.27 | | 110.8 |
| 5 years | 71.27 | | 110.8 |
| 10 years | 63.23 | | 110.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 57 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 64 | 2020-04-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.25% | -0.03% | -7.56% | -17.30% | 109B | |
| -0.87% | +4.04% | +58.60% | +163.92% | 1,089B | |
| -0.45% | +3.87% | +57.95% | +52.18% | 643B | |
| +0.04% | +3.95% | +37.69% | +74.54% | 465B | |
| -1.69% | +8.81% | +39.38% | +34.26% | 359B | |
| -0.51% | +3.51% | +36.97% | +43.76% | 303B | |
| +1.50% | +3.40% | +17.71% | +18.77% | 267B | |
| +0.79% | +5.81% | -2.55% | -36.02% | 226B | |
| -1.39% | +5.90% | +27.70% | +64.00% | 212B | |
| -1.18% | +1.83% | +16.20% | +72.69% | 167B | |
| Average | -0.42% | +4.77% | +28.21% | +47.08% | 414.57B | |
| Weighted average by Cap. | -0.51% | +4.90% | +40.58% | +76.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.15B 53.66B 44.01B 40.39B 75.61B 5,140B 77.48B 522B 204B 2,543B 201B 197B 8,793B | 50.34B 57.28B 46.98B 43.12B 80.72B 5,487B 82.71B 557B 218B 2,715B 215B 210B 9,386B |
| Net income | 8.44B 9.6B 7.87B 7.23B 13.53B 920B 13.86B 93.38B 36.52B 455B 36.05B 35.27B 1,573B | 9.44B 10.74B 8.81B 8.08B 15.13B 1,029B 15.51B 104B 40.85B 509B 40.32B 39.45B 1,760B |
| Net Debt | 9.8B 11.16B 9.15B 8.4B 15.72B 1,069B 16.11B 109B 42.43B 529B 41.89B 40.98B 1,828B | 6.15B 6.99B 5.74B 5.26B 9.85B 670B 10.1B 68.02B 26.6B 331B 26.26B 25.69B 1,146B |
| Date | Price | Change |
|---|---|---|
| 26-07-29 | €79.34 | +0.25% |
| 26-07-28 | €79.14 | +2.38% |
| 26-07-27 | €77.30 | +2.18% |
| 26-07-24 | €75.65 | -1.48% |
| 26-07-23 | €76.79 | +0.37% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- SNW Stock
Select your edition
All financial news and data tailored to specific country editions
